Verified peer comparison
aTyr Pharma vs UY Scuti Acquisition Financial Comparison
Direct answer
aTyr Pharma and UY Scuti Acquisition are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free aTyr Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- aTyr Pharma Revenue
- 190,000 USD
- UY Scuti Acquisition Revenue
- 0 USD
- aTyr Pharma Operating income
- -77,627,000 USD
- UY Scuti Acquisition Operating income
- -156,520 USD